This Undervalued Biotech Penny Stock Could Soon Double

Penny stocks have a poor reputation, but the chance of finding a diamond in the rough keeps some traders coming back to them again and again. Thankfully, with a bit of critical-minded sifting through the endless dunes of forgettable small-cap stocks, investors can find a few worth considering.

BioDelivery Sciences International (NASDAQ: BDSI) has the potential to be just such an unrecognized gem. The biopharma company is profitable, making headway against its competitors and expanding its revenue at a steady clip. Plus, its stock appears to be undervalued, and management is working on rewarding shareholders. In short, its shares are ripe for an explosion of growth that could double or even triple their value.

Image source: Getty Images.

Source Fool.com